Overall verdict
Neutral
5.5/10
1-year performance
-2.77%
Score breakdown
Down 2.8% over 1 year, 76% of the 52-week range.
Strongest: Shareholder return 9.7/10. Weakest: Growth 2.0/10.
20 analysts, target +0.1% vs the price.
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China. It operates in four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment offers magnetic resonance imaging, computed tomography, X-ray, molecular imaging, and ultrasound systems; and software solutions to support the reading and structured reporting of diagnostic images from different modalities.
Its Diagnostics segment provides in-vitro diagnostic products and services to healthcare providers in the fields of general and specialty laboratory, and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment offers microwave, cryoablation, and embolization technologies, as well as clinical professional services for cancer care that support oncology departments in hospitals and clinics; and customized support for cancer care operations.
Its Advanced Therapies segment provides products that are designed to support image-guided minimally invasive clinical procedures in various areas, such as cardiology, neurology, and oncology; angiography systems and mobile C-arms; and AI-powered clinical applications. It also offers essential technical customer service, such as maintenance and repair ; spare parts ; medical equipment performance management ;
training ; clinical education and e-learning ; planning and design ; financing ; asset management ; and managed departmental services for laboratories and healthcare facilities, as well as healthcare consulting, products, and services. It has strategic partnership with IFS and Novo. The company was founded in 1896 and is headquartered in Forchheim, Germany. Siemens Healthineers AG is a subsidiary of Siemens Aktiengesellschaft.
Sector
Health Care
Industry
Health Care Equipment and Supplies
Primary listing
Xetr
Germany
CEO
Dr. Bernhard Montag Ph.D.
Founded
1896
Employees
74 600
Revenue / employee
316 756 EUR
Next earnings
November 25, 2026
Research uses the underlying stock’s market history. The purchase quote is calculated separately when you review your order.
52-week high
47.26 EUR
52-week low
32.81 EUR
1-year performance
-2.77%
Declining
Year-to-date performance
-2.38%
Declining
Drawdown
-7.32%
Mild pullback
Position in the 52-week range
76% of range
Range: 47.53 EUR - 51.18 EUR (3 methods agree)
The price implies growth of 7.32% per year; the company grows at 4.71%.
Gross margin 38.6%, net margin 9.4%, ROIC 7.3%, ROE 11.7%.
Net margin
9.37%
Fair
Sector 9.11%|S&P 13.40%
Gross margin
38.57%
Low
Return on equity (ROE)
11.69%
Exceptional
Sector 7.42%|S&P 17.06%
Return on invested capital (ROIC)
7.29%
Fair
Free cash flow margin (FCF)
8.60%
Fair
Profit-to-cash conversion (FCF conversion)
0.92x
Fair
Margin stability
0.9 pts
Very steady
Revenue to net income
Growth
2.0/10Revenue up 7.3% over 1 year, 5.6% a year over 5, EPS 4.7% a year over 5.
Revenue (trailing 12 months)
23.6Md EUR
Revenue growth (1y)
7.31%
Moderate
Revenue growth (3y)
8.99%
Moderate
EPS growth (1y)
3.14%
Moderate
EPS CAGR (5y)
4.71%
Low
EPS revisions (3 months)
-1.58%
Revised down
Valuation
4.8/10P/E 22.1x, forward P/E 23.0x, EV/EBITDA 13.4x, PEG 4.70. The multiple sits in the 18th percentile of its own 5-year history.
P/E (TTM)
22.1x
Fair
Sector 29.3x|S&P 23.6x
Forward P/E
23.0x
Fair
EV / EBITDA
13.4x
Fair
Sector 14.4x|S&P 15.5x
PEG
4.70
Very expensive
Sector 1.25|S&P 0.91
Fair value (reverse DCF)
49.36 EUR
Undervalued
P/E vs its own 5-year history
among the 18% lowest valuations
Far cheaper than usual
Market cap
48.5Md EUR
Financial strength
5.8/10Cash covers 17.2% of the debt, net debt/EBITDA 2.8x.
Net debt / EBITDA
2.8x
Stretched
Gearing (net debt / equity)
61.25%
Tight
Cash
2.5Md EUR
Cash / market cap
5.24%
Tight
Cash / total debt
17.24%
Tight
Interest coverage
8.2x
Solid
Net debt
12.2Md EUR
Equity
19.9Md EUR
Closed daily candles, 2 years
Last close on November 11, 2026: 43.58 EUR
- MM2042.65
- MM5040.11
- MM20037.90
- RSI 1461.4
Top panel: closed candles, 20, 50 and 200-day moving averages, with volume in grey. Bottom panel: 14-day RSI with dashed 30 and 70 levels.
200-day average slope, 1 month
-0.64%
200-day average slope, 3 months
-3.46%
50-day average slope, 1 month
+3.33%
Price structure
Lower lows
Bullish RSI divergence
No
20-day volatility
1.43 % per day
Volatility change
+3.85%
Forecasts by fiscal year
| Fiscal year | EPS | Normalised EPS | Revenue | EBITDA | Net income |
|---|---|---|---|---|---|
| 2027 | 1.91 (14) | 2.33 (19) | 24 798 (11) | 4 732 (16) | 2 109 (12) |
Amounts in millions of EUR, EPS in EUR per share. In brackets, the number of analysts. Consensus as of November 11, 2026.
Same sub-industry: 187 companies behind the medians.
| # | Company | Code | Country | Overall / 10 | Fundamentals / 10 | Mkt cap | P/E | Net margin | Revenue growth | ROIC | Net debt / EBITDA | FCF yield | 1-year perf. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SYK | 6.5 | 6.1 | 121Md USD | 34.0x | 13.8 % | 7.6 % | 9.7 % | 1.7x | 3.8 % | -10.5 % | ||
| 2 | IDXX | 6.3 | 5.7 | 55.4Md USD | 47.4x | 25.4 % | 9.9 % | 54.9 % | 0.5x | 2.3 % | -1.2 % | ||
| 3 | ISRG | 6.2 | 5.5 | 156Md USD | 54.4x | 25.5 % | 21.7 % | 18.0 % | -1.6x | 2.3 % | -21.8 % | ||
| 4 | MDT | 6.2 | 6.7 | 130Md USD | 25.0x | 13.9 % | 13.7 % | 7.0 % | 2.0x | 4.7 % | 9.3 % | ||
| 5 | ABT | 6.0 | 5.2 | 189Md USD | 40.3x | 9.8 % | 14.5 % | 6.6 % | 0.5x | 3.6 % | -13.7 % | ||
| 6 | EW | 5.9 | 5.1 | 60.8Md USD | 61.6x | 14.9 % | 10.5 % | 8.9 % | -2.0x | 2.3 % | 25.3 % | ||
| 7 | BSX | 5.6 | 6.4 | 65.4Md USD | 19.1x | 16.6 % | 1.4 % | 9.8 % | 1.8x | 5.1 % | -55.5 % | ||
| 8 | BDX | 5.5 | 5.3 | 58.4Md USD | 51.8x | 7.4 % | -10.5 % | 3.6 % | 2.9x | 4.6 % | 49.4 % | ||
| 9 | SHL | 5.5 | 5.3 | 53.8Md USD | 22.1x | 9.4 % | 7.3 % | 7.3 % | 2.8x | 4.2 % | -2.8 % |
